References
- Kirtschig G, Middleton P, Bennett C, Murrell DF, Wojnarowska F, Khumalo NP. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;CD002292.
- Borradori L, Bernard P. Vesiculobullous diseases: pemphigoid group. In: Bologna JL, Jorizzo JL, Rapini RP, editors. Dermatology. London, UK: Elsevier-Mosby, 2008. p 431–438.
- Kasperkiewicz M, Schmidt E. Current treatment of autoimmune blistering diseases. Curr Drug Discov Technol. 2009;6:270–280.
- Patricio P, Ferreira C, Gomes MM, Filipe P. Autoimmune bullous dermatoses: a review. Ann NY Acad Sci. 2009;1173:203–210.
- Troiano M, Lotti T. Rituximab in dermatological diseases. G Ital Dermatol Venereol. 2009;144:495–499.
- Lever WF, Hashimoto K. The etiology and treatment of pemphigus and pemphigoid. J Invest Dermatol. 1969;53:373–389.
- Bara C, Maillard H, Briand N, Celerier P. Methotrexate for bullous pemphigoid: preliminary study. Arch Dermatol. 2003;139:1506–1507.
- Dereure O, Bessis D, Guillot B, Guilhou JJ. Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18 cases. Arch Dermatol. 2002;138:1255–1256.
- Downham TF, Chapel TA. Bullous pemphigoid:therapy in patients with and without diabetes mellitus. Arch Dermatol. 1978;114:1639–1642.
- Gurcan HM, Ahmed AR. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid. Br J Dermatol. 2009;161:723–731.
- Heilborn JD, Stahle-Backdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E. Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid. J Am Acad Dermatol. 1999;40:741–749.
- Kjellman P, Eriksson H, Berg P. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate. Arch Dermatol. 2008;144:612–616.
- Paul MA, Jorizzo JL, Fleischer AB Jr, White WL. Low-dose methotrexate treatment in elderly patients with bullous pemphigoid. J Am Acad Dermatol. 1994;31:620–625.